ContractSynageva Biopharma Corp • November 14th, 2011 • Biological products, (no disgnostic substances) • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT’), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.
ContractSynageva Biopharma Corp • November 14th, 2011 • Biological products, (no disgnostic substances) • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.
Synageva BioPharma Corp. LEDGEMONT DEVELOPMENT CENTER LEXINGTON, MACommencement Date Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances)
UNIVERSITY OF MINNESOTA EXCLUSIVE PATENT LICENSE AGREEMENTExclusive Patent License Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • Delaware
THIS EXCLUSIVE PATENT LICENSE AGREEMENT (the “Agreement”) is made by and between Regents of the University of Minnesota, a constitutional corporation under the laws of the state of Minnesota, having a place of business at 1000 Westgate Drive, Suite 160, St. Paul, Minnesota 55114 (the “University”), and the Licensee indentified below.
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is entered into as of , by and between Synageva BioPharma Corp., a Delaware corporation (the “Company”), and , an individual (“Indemnitee”).
RENTAL AGREEMENTRental Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • Georgia
THIS RENTAL AGREEMENT (hereinafter referred to as “Agreement”), is made and entered into as of this 1st day of July, 2011, (hereinafter referred to as the “Effective Date”), by and between the BOARD OF REGENTS OF THE UNIVERSITY SYSTEM OF GEORGIA, (hereinafter referred to as “Landlord”), whose address for purposes of this Agreement is 270 Washington Street, Atlanta, Georgia 30334, and Synageva BioPharma Corp., (hereinafter referred to as “Tenant”), whose address for purposes of this Agreement is 111 Riverbend Road, Athens, GA 30605 for the use of certain property located upon the campus of The University of Georgia, a unit of the University System of Georgia (hereinafter referred to as “Institution”).
NON-EXCLUSIVE SUBLICENSE AGREEMENT between PANGEN1X and AviGenics Inc. for Viral Particles Having Altered Host Range (VSV) For Birds 1st Amendment, April 1, 2003Non-Exclusive Sublicense Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • California
THIS SUB-LICENSE AGREEMENT (the “Agreement”) is effective as of 5 December 2000 (the “Effective Date”) between PANGENIX, a California corporation having a place of business at 6505 El Camino del Teatro, La Jolla, CA 92037-6337 (“Pangenix”), as sublicensor, and AviGenics, Inc., a corporation having a place of business at 111 Riverbend Road, Athens, GA -30605.
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • November 14th, 2011 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • Georgia
THIS AMENDED AND RESTATED LICENSE AGREEMENT is made and entered into as of this 5th day of April 2007 (“EFFECTIVE DATE”) by and between the UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., a nonprofit Georgia corporation with offices in the Boyd Graduate Studies Research Center, The University of Georgia, Athens, Georgia 30602 (“UGARF”) and AVIGENICS, INC., a Delaware corporation, having offices at Georgia BioBusiness Center, 111 Riverbend Road, Athens, GA 30605 (“AviGenics”).
